Form 8-K - Current report:
SEC Accession No. 0001654954-25-000570
Filing Date
2025-01-21
Accepted
2025-01-21 08:05:55
Documents
17
Period of Report
2025-01-17
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K drma_8k.htm   iXBRL 8-K 35900
2 CLINICAL TRIAL COLLABORATION AGREEMENT drma_ex101.htm EX-10.1 198509
3 PRESS RELEASE drma_ex991.htm EX-99.1 31063
  Complete submission text file 0001654954-25-000570.txt   466274

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA drma-20250117.xsd EX-101.SCH 6311
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE drma-20250117_lab.xml EX-101.LAB 16880
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE drma-20250117_cal.xml EX-101.CAL 898
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE drma-20250117_pre.xml EX-101.PRE 12342
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE drma-20250117_def.xml EX-101.DEF 4203
19 EXTRACTED XBRL INSTANCE DOCUMENT drma_8k_htm.xml XML 5822
Mailing Address 3525 DEL MAR HEIGHTS RD., #322 SAN DIEGO CA 92130
Business Address 3525 DEL MAR HEIGHTS RD., #322 SAN DIEGO CA 92130 (858)-223-0882
Dermata Therapeutics, Inc. (Filer) CIK: 0001853816 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40739 | Film No.: 25540488
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)